No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5

被引：0
|
作者：
Riddell, Michael C.
Heller, Simon R.
Asong, Marisse
Carstensen, Lisbeth
Watt, Sara K.
Woo, Vincent C.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-830-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
830-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
    Bajaj, Harpreet S.
    Bergenstal, Richard M.
    Christoffersen, Andreas
    Davies, Melanie J.
    Gowda, Amoolya
    Isendahl, Joakim
    Lingvay, Ildiko
    Senior, Peter A.
    Silver, Robert J.
    Trevisan, Roberto
    Rosenstock, Julio
    DIABETES CARE, 2021, 44 (07) : 1586 - 1594
  • [42] Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
    Hovelmann, Ulrike
    Brondsted, Lise
    Kristensen, Niels R.
    Ribel-Madsen, Rasmus
    Devries, J. Hans
    Heise, Tim
    Haahr, Hanne
    DIABETES, 2020, 69
  • [43] Insulin icodec: an insulin analogue suited for once-weekly dosing in type 2 diabetes
    Hovelmann, U.
    Brondsted, L.
    Kristensen, N. R.
    Ribel-Madsen, R.
    DeVries, J. H.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S316 - S316
  • [44] Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
    Ribeiro e Silva, Rodrigo
    Gauza, Mateus de Miranda
    Schramm Guisso, Maria Eduarda
    Nunes da Silva, Julia Opolski
    Kohara, Suely Keiko
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67 (05):
  • [45] Once-weekly insulin icodec: pharmacokinetic and pharmacodynamic properties in type 1 diabetes
    Hoevelmann, U.
    Engberg, S.
    Heise, T.
    Kristensen, N. R.
    Norgreen, L.
    Ribel-Madsen, R.
    Zijlstra, E.
    Haahr, H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S399 - S400
  • [46] Once-weekly Insulin Icodec: An emerging treatment option for type 2 Diabetes
    Zahra, Rubab
    Tariq, Fasiha
    Ahmed, Mushood
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (08) : 1583 - 1583
  • [47] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [48] Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
    Philis-Tsimikas, Athena
    Asong, Marisse
    Franek, Edward
    Jia, Ting
    Rosenstock, Julio
    Stachlewska, Karolina
    Watada, Hirotaka
    Kellerer, Monika
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (06): : 414 - 425
  • [49] Hypoglycaemia frequency and physiological response to double or triple doses of once weekly insulin icodec vs. once-daily insulin glargine U100 in type 2 diabetes
    Svehlikova, Eva
    Arfelt, Kristine Niss
    Cailleteau, Roma
    Deller, Sigrid
    Thomsen, Karen Margret Due
    Hart, Marlies
    Mursic, Ines
    Pieber, Thomas
    Haahr, Hanne
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 262 - 263
  • [50] Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (Sept, 10.7326/M23-1288, 2023)
    Bajaj, H. S.
    Aberle, J.
    Davies, M.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1688 - 1688
12345